Krka Tovarna Zdravil D.D. 

€232
77
+€2+0.87% Today

Statistics

Day High
232
Day Low
230
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
7.61B
P/E Ratio
17.41
Dividend Yield
3.56%
Dividend
8.25

Upcoming

Dividends

3.56%Dividend Yield
Jul 25
€8.25
Jul 24
€7.5
Jul 23
€6.6
Jul 22
€5.63
Jul 21
€5
10Y Growth
12.03%
5Y Growth
10.53%
3Y Growth
7.72%
1Y Growth
N/A

Financials

18.69%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.82BRevenue
713.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KN8.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Krka in various therapeutic areas.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Krka's offerings in the global market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries is a leading generic and specialty pharmaceutical company, competing with Krka in the generics market.
Merck
MRK
Mkt Cap298.84B
Merck & Co. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Krka in several therapeutic areas.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a global healthcare company that produces pharmaceuticals and vaccines, directly competing with Krka in various markets.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie is a biopharmaceutical company that develops and markets therapies, competing with Krka in the areas of chronic diseases.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG is a healthcare company that operates in pharmaceuticals and diagnostics, competing with Krka in the development and marketing of drugs.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb is a global biopharmaceutical company, competing with Krka in the discovery, development, and delivery of medicines.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, competing with Krka in various therapeutic areas.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Krka in developing and commercializing prescription medicines.

About

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; cerebral and peripheral circulation; vasoprotectives; health care products; and others. In addition, the company offers animal health products comprising antiparasitics, antimicrobials, and other products. Further, the company provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
Show more...
CEO
Dr. Jo?e Colaric
Employees
13236
Country
DE
ISIN
SI0031102120
WKN
000903246

Listings

0 Comments

Share your thoughts

FAQ

What is Krka Tovarna Zdravil D.D. stock price today?
The current price of KN8.F is €232 EUR — it has increased by +0.87% in the past 24 hours. Watch Krka Tovarna Zdravil D.D. stock price performance more closely on the chart.
What is Krka Tovarna Zdravil D.D. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Krka Tovarna Zdravil D.D. stocks are traded under the ticker KN8.F.
What is Krka Tovarna Zdravil D.D. market cap?
Today Krka Tovarna Zdravil D.D. has the market capitalization of 7.61B
What is Krka Tovarna Zdravil D.D. revenue for the last year?
Krka Tovarna Zdravil D.D. revenue for the last year amounts to 3.82B EUR.
What is Krka Tovarna Zdravil D.D. net income for the last year?
KN8.F net income for the last year is 713.97M EUR.
Does Krka Tovarna Zdravil D.D. pay dividends?
Yes, KN8.F dividends are paid annual. The last dividend per share was 8.25 EUR. As of today, Dividend Yield (FWD)% is 3.56%.
How many employees does Krka Tovarna Zdravil D.D. have?
As of April 08, 2026, the company has 13,236 employees.
When did Krka Tovarna Zdravil D.D. complete a stock split?
Krka Tovarna Zdravil D.D. has not had any recent stock splits.
Where is Krka Tovarna Zdravil D.D. headquartered?
Krka Tovarna Zdravil D.D. is headquartered in Novo Mesto, DE.